DSpace university logo mark
詳細検索
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > 030 医学部 > 030 紀要 > Acta Medica Nagasakiensia > Volume 60, No. 2 >

The efficacy of magnesium in preventing renal dysfunction due to high-dose cisplatin for treatment of thoracic tumor


ファイル 記述 サイズフォーマット
ActMed60_39.pdf886.41 kBAdobe PDF本文ファイル

タイトル: The efficacy of magnesium in preventing renal dysfunction due to high-dose cisplatin for treatment of thoracic tumor
著者: Motoshima, Kohei / Nakamura, Yoichi / Shimada, Midori / Kitazaki, Takeshi / Senju, Hiroaki / Ogawara, Daiki / Takemoto, Shinnosuke / Mizoguchi, Kosuke / Sato, Shuntaro / Nakatomi, Katsumi / Fukuda, Minoru / Kohno, Shigeru
発行日: 2016年 1月
出版者: Nagasaki University School of Medicine / 長崎大学医学部
引用: Acta medica Nagasakiensia, 60(2), pp.39-44; 2016
抄録: Objective: Cisplatin is well known for producing severe adverse events, including renal dysfunction. To prevent renal dysfunction caused by cisplatin, routine magnesium supplementation is recommended. However, few reports exist about the efficacy of magnesium in preventing renal dysfunction. Therefore, the purpose of this study was to retrospectively survey the efficacy of magnesium in preventing renal dysfunction after administration of cisplatin. Methods: We evaluated patients who received first-line cisplatin-based chemotherapy from May 2008 to June 2013. Results: Data from 146 patients and a total of 394 treatments was analyzed. Elevation of serum creatinine was detected in 77 / 394 treatments (19.5%). Statistical significance was found between prevention of elevation of serum creatinine and magnesium supplementation. The other significant parameters were serum creatinine and eGFR levels before treatment and patient age. In multivariate analysis, magnesium and eGFR before treatment were statistically significant. Conclusions: The study results suggest that magnesium supplementation might reduce nephrotoxicity caused by cisplatin. The eGFR level before treatment might be an important factor associated with nephrotoxicity after cisplatin administration.
キーワード: cisplatin / renal dysfunction / magnesium / eGFR
URI: http://hdl.handle.net/10069/36167
ISSN: 00016055
資料タイプ: Departmental Bulletin Paper
原稿種類: publisher
出現コレクション:Volume 60, No. 2

引用URI : http://hdl.handle.net/10069/36167

このリポジトリに保管されている文献はすべて著作権により保護されています。
印刷やダウンロード等データの複製は、調査研究・教育または学習を目的とする場合に限定されます。

 

Valid XHTML 1.0! Copyright © 2006-2015 長崎大学附属図書館 - お問い合わせ Powerd by DSpace